Oral Kaposi's sarcoma in a renal transplant patient: case report and literature review.
Malignancies, including oral Kaposi's sarcoma, may develop in transplant patients as a result of immunosuppressive therapy. Both the prevalence and the incidence of these malignancies vary. This article describes a renal transplant patient who was receiving immunosuppressive therapy and presented with oral Kaposi's sarcoma. The lesion was excised and did not recur. However, the patient died as a result of viral pneumonitis, secondary to her renal problems. The article also includes a review of the literature, with particular emphasis on oral presentation of immunosuppression-related malignancies.
Darling
Mark
M
Department of Pathology, Faculty of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada. mark.darling@fmd.uwo.ca
Thompson
Ivor
I
Meer
Mohammed
M
D001379:Azathioprine / Q000009:adverse effects; D016572:Cyclosporine / Q000009:adverse effects; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000009:adverse effects; D008875:Middle Aged; D010157:Palatal Neoplasms / Q000209:etiology* / Q000473:pathology; D011014:Pneumonia / Q000209:etiology; D012514:Sarcoma, Kaposi / Q000209:etiology* / Q000473:pathology
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine